Literature DB >> 18517265

Malignant fibrous histiocytoma: between the past and the present.

Osama M Al-Agha1, Anne A Igbokwe.   

Abstract

The precise nature and diagnostic concept of malignant fibrous histiocytoma (MFH) has been debated for years. Currently, a histiocytic lineage of the tumor cells is no longer favored. The nomenclature and classification of MFH and its subtypes have also been changed. The MFH pattern, especially that of storiform-pleomorphic variant, is viewed as a morphologic pattern shared by a number of sarcomas as well as by other nonsarcomas. Therefore, a diagnosis of MFH based solely on morphology is no longer acceptable and identification of a line of differentiation should be sought. A diagnosis of MFH should be made only for pleomorphic sarcomas in which no specific line of differentiation is discerned. Precise categorization of MFH-like tumors may require thorough sampling of the tumor and judicious use of immunohistochemistry and/or electron microscopy. Familiarity with the current terminology and classification of MFH and its subtypes is of paramount significance in the modern practice of pathology.

Entities:  

Mesh:

Year:  2008        PMID: 18517265     DOI: 10.5858/2008-132-1030-MFHBTP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  34 in total

1.  Soft tissue sarcoma with metastasis to the stomach: a case report.

Authors:  Lemuel Leon Dent; Cesar Yamil Cardona; Michael Clause Buchholz; Roosevelt Peebles; Julie Denise Scott; Derrick Jerome Beech; Billy Ray Ballard
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

Review 2.  Malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma of the maxillary sinus: report of a case and review of the literature.

Authors:  Drazsen Vuity; Sandor Bogdan; Katalin Csurgay; Zoltan Sapi; Zsolt Nemeth
Journal:  Pathol Oncol Res       Date:  2013-06-29       Impact factor: 3.201

Review 3.  Radiation-induced malignant fibrous histiocytoma of the maxilla.

Authors:  Takafumi Satomi; Masato Watanabe; Tadayoshi Kaneko; Jun Matsubayashi; Toshitaka Nagao; Hiroshige Chiba
Journal:  Odontology       Date:  2011-04-13       Impact factor: 2.634

4.  An entire clinical course of mediastinal myxofibrosarcoma treated by surgery and radiation.

Authors:  Yasoo Sugiura; Hiroyuki Fujimoto; Toshinori Hashizume; Go Ogura; Etsuo Nemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-10

5.  Right cardiac intracavitary metastases from a primary intracranial myxofibrosarcoma.

Authors:  Diogo Alpuim Costa; Pedro Barata; Emanuel Gouveia; Manuela Mafra
Journal:  BMJ Case Rep       Date:  2016-03-24

6.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03

7.  Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors.

Authors:  Seiko Toyozawa; Yuki Yamamoto; Yuko Ishida; Toshikazu Kondo; Yasushi Nakamura; Fukumi Furukawa
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

8.  Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

Authors:  Marc Becker; Claudine Graf; Marcus Tonak; Markus P Radsak; Tobias Bopp; Robert Bals; Rainer M Bohle; Matthias Theobald; Pol-Maria Rommens; Dirk Proschek; Thomas C Wehler
Journal:  Oncol Lett       Date:  2016-06-24       Impact factor: 2.967

9.  Myxofibrosarcoma arising in the maxillary sinus: a case report with a review of the ultrastructural findings and differential diagnoses.

Authors:  Ernst J G Norval; Erich J Raubenheimer
Journal:  J Maxillofac Oral Surg       Date:  2011-07-27

10.  Computed tomography and magnetic resonance imaging findings of malignant fibrous histiocytoma of the head and neck.

Authors:  Jing Li; Zhi-Jun Geng; Xiao-Fei Lv; Xin-Ke Zhang; Chuan-Miao Xie
Journal:  Mol Clin Oncol       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.